Alertas Bibliográficas


DIABETES

Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings. 
Shaw JL, Bannuru RR, Beach L et al.
Diabetes Care. 2024. 
https://doi.org/10.2337/dci24-0073

De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D). 
Rodriguez P, Breslaw N, Xiao H et al. 
Diabetes Obes Metab. 2024.
https://doi.org/10.1111/dom.16057

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). 
Tacke F, Horn P, Wai-Sun Wong V et al.
J Hepatol. 2024 Sep;81(3):492-542.
https://doi.org/10.1016/j.jhep.2024.04.031


ENDOCRINOLOGÍA

Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol. 
Lanzolla G, Marinò M, Menconi F. 
Published online July 22, 2024. 
doi:10.1038/s41574-024-01016-5


PEDIATRÍA

Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al.
N Engl J Med. 2019 Aug 15;381(7):637-646.
http://doi.org/10.1056/NEJMoa1903822

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D, Aversa T, Ruggeri RM, Cristani M, Alibrandi A, et al.
Front Endocrinol (Lausanne). 2019 Jun 28;10:426.
http://doi.org/10.3389/fendo.2019.00426


CIENCIAS BÁSICAS